Alexandria Real Estate Equities
ARE
#2439
Rank
NZ$13.51 B
Marketcap
NZ$78.53
Share price
-3.72%
Change (1 day)
-39.70%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -NZ$1.06 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are NZ$2.85 Billion. In 2025 the company made an earning of -NZ$1.68 Billion a decrease over its 2024 earnings that were of NZ$1.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.06 Billion-36.87%
2025 -NZ$1.68 Billion-242.13%
2024 NZ$1.18 B96.11%
2023 NZ$0.60 B-53.56%
2022 NZ$1.29 B-3.96%
2021 NZ$1.34 B-20.26%
2020 NZ$1.69 B72.88%
2019 NZ$0.97 B3.11%
2018 NZ$0.94 B73.54%
2017 NZ$0.54 B464.88%
2016 NZ$96.83 M-77.32%
2015 NZ$0.42 B36.31%
2014 NZ$0.31 B-10.81%
2013 NZ$0.35 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.94 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$52.73 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.39 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$18.17 B-1,839.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.96 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.26 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.47 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA